Skip to main content
Equibles

Squarepoint Ops LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1642575 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,876,721
+$2,042,761 QoQ
Shares Held
569,269
+38.8% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#52
of 208 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. TSHA ranks #55 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in TSHA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,876,721 569,269
2026-03-31 $1,833,960 410,282
2025-12-31 $2,593,673 471,577
2025-09-30 $648,611 198,352
2025-06-30 $231,522 100,226
2024-12-31 $366,486 211,842
2024-09-30 $207,277 103,123
2024-06-30 $179,771 80,255
2024-03-31 $614,025 213,946
2023-12-31 $112,354 63,477
2023-09-30 $90,274 28,568
2023-06-30 $53,299 80,634
2021-12-31 $340,296 29,210